Showing results (21-30 of 225) with videos related to

Sort By:
Pageof 23
European Journal of Cancer (Oxford, England : 1990)|August 14, 2022
Triplet therapy with androgen deprivation, docetaxel, and androgen receptor signalling inhibitors in metastatic castration-sensitive prostate cancer: A meta-analysisChiara Ciccarese, Roberto Iacovelli, Cora N Sternberg, et al.
Tumori|February 18, 2015
Rationale and protocol of SOAP: a phase II study to evaluate the efficacy of sorafenib as second-line treatment after pazopanib in patients with advanced renal cell carcinomaRoberto Iacovelli, Elena Verzoni, Paolo Grassi, et al.
Therapeutic Advances in Urology|April 2, 2015
Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenibPaolo Grassi, Elena Verzoni, Luca Porcu, et al.
Acta Bio-Medica : Atenei Parmensis|September 23, 2010
Dermatomyositis as first clinical appearance for a thymic epidermoid cell carcinomaRoberto Iacovelli, Antonella Palazzo, Davide Conte, et al.
Anticancer Research|January 25, 2008
Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-upAntonio Frega, Ankica Lukic, Flavia Nobili, et al.
European Urology|December 4, 2014
Evidence and Clinical Relevance of Tumor Flare in Patients Who Discontinue Tyrosine Kinase Inhibitors for Treatment of Metastatic Renal Cell CarcinomaRoberto Iacovelli, Francesco Massari, Laurence Albiges, et al.
Therapeutic Advances in Urology|July 2, 2021
Second-line treatment in renal cell carcinoma: clinical experience and decision makingValentina Guadalupi, Giacomo Cartenì, Roberto Iacovelli, et al.
BJU International|March 29, 2012
Clinical and pathological features of primary renal synovial sarcoma: analysis of 64 cases from 11 years of medical literatureRoberto Iacovelli, Amelia Altavilla, Antonio Ciardi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2020
Patients with sarcomatoid renal cell carcinoma - re-defining the first-line of treatment: A meta-analysis of randomised clinical trials with immune checkpoint inhibitorsRoberto Iacovelli, Chiara Ciccarese, Emilio Bria, et al.
American Journal of Clinical Oncology|February 8, 2013
Management of metastatic renal cell carcinoma progressed after sunitinib or another antiangiogenic treatmentRoberto Iacovelli, Antonella Palazzo, Patrizia Trenta, et al.
Pageof 23